161 related articles for article (PubMed ID: 32612424)
1. Paraoxonase Activity and Phenotype Distribution in Patients with Chronic Obstructive Pulmonary Disease.
Sarioglu N; Bilen C; Cevik C; Gencer N
Eurasian J Med; 2020 Jun; 52(2):161-165. PubMed ID: 32612424
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients.
Sarioglu N; Hismiogullari AA; Erel F; Demir D; Gencer N
Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):60-6. PubMed ID: 25530140
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease.
Rumora L; Rajković MG; Kopčinović LM; Pancirov D; Čepelak I; Grubišić TŽ
COPD; 2014 Sep; 11(5):539-45. PubMed ID: 24831724
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 Activity and Phenotype Distribution in Lumbar Disc Herniation Patients.
Adilay U; Gencer N; Cikrikci K; Sari MF; Abdallah EA; Guclu B
Turk Neurosurg; 2023 Aug; ():. PubMed ID: 38874244
[TBL] [Abstract][Full Text] [Related]
5. Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction.
Rahman MF; Hashad IM; Abou-Aisha K; Abdel-Maksoud SM; Gad MZ
Arch Med Sci; 2015 Jun; 11(3):513-20. PubMed ID: 26170843
[TBL] [Abstract][Full Text] [Related]
6. The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypes.
Mahrooz A; Alizadeh A; Gohari G
J Neurol Sci; 2014 Mar; 338(1-2):197-202. PubMed ID: 24433930
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
Watanabe J; Kotani K; Gugliucci A
Antioxidants (Basel); 2021 Nov; 10(12):. PubMed ID: 34942993
[TBL] [Abstract][Full Text] [Related]
8.
Grdić Rajković M; Popović-Grle S; Vukić Dugac A; Rogić D; Rako I; Radić Antolić M; Beriša M; Rumora L
J Clin Pathol; 2018 Nov; 71(11):963-970. PubMed ID: 29858231
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase activity in healthy, diabetic, and hemodialysis patients.
Gbandjaba NY; Ghalim N; Hassar M; Berrougui H; Labrazi H; Taki H; Saile R; Khalil A
Clin Biochem; 2012 Apr; 45(6):470-4. PubMed ID: 22285382
[TBL] [Abstract][Full Text] [Related]
10. Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans.
Taravati A; Ardestani SK; Ziaee AA; Ghorbani A; Soroush MR; Faghihzadeh S; Kazemi H; Rezaei A; Hoseini H; Ghazanfari T
Int Immunopharmacol; 2013 Nov; 17(3):974-9. PubMed ID: 23370296
[TBL] [Abstract][Full Text] [Related]
11. The determination of Q192R polymorphism of paraoxonase 1 by using non-toxic substrate p-nitrophenylacetate.
Mogarekar MR; Chawhan SS
Indian J Hum Genet; 2013 Jan; 19(1):71-7. PubMed ID: 23901196
[TBL] [Abstract][Full Text] [Related]
12. Effects of aerobic training on serum paraoxonase activity and its relationship with PON1-192 phenotypes in women.
Nalcakan GR; Varol SR; Turgay F; Nalcakan M; Ozkol MZ; Karamizrak SO
J Sport Health Sci; 2016 Dec; 5(4):462-468. PubMed ID: 30356554
[TBL] [Abstract][Full Text] [Related]
13. Association of cadmium, lead and mercury with paraoxonase 1 activity in women.
Pollack AZ; Sjaarda L; Ahrens KA; Mumford SL; Browne RW; Wactawski-Wende J; Schisterman EF
PLoS One; 2014; 9(3):e92152. PubMed ID: 24682159
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 Phenotype and Mass in South Asian versus Caucasian Renal Transplant Recipients.
Connelly PW; Maguire GF; Nash MM; Rapi L; Yan AT; Prasad GV
J Lipids; 2012; 2012():608580. PubMed ID: 22701797
[TBL] [Abstract][Full Text] [Related]
15. Phenotype distribution of the paraoxonase gene in patients with cardiac disease.
Ellidag HY; Aydin O; Eren E; Yilmaz N; Gencpinar T; Kucukseymen S; Yilmaz A; Arslan Ince FD
Arch Med Sci; 2017 Jun; 13(4):820-826. PubMed ID: 28721150
[TBL] [Abstract][Full Text] [Related]
16. A prospective study to assess the role of paraoxonase 1 genotype and phenotype on the lipid-lowering and antioxidant activity of statins.
Godbole C; Thaker S; Salagre S; Shivane V; Gogtay N; Thatte U
Indian J Pharmacol; 2023; 55(3):179-184. PubMed ID: 37555413
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis.
Atar A; Gedikbasi A; Sonmezay E; Kiraz ZK; Abbasoglu S; Tasci AI; Tugcu V
Ren Fail; 2016; 38(3):378-82. PubMed ID: 26795139
[TBL] [Abstract][Full Text] [Related]
18. Association of Paraoxonse1 (PON1) Genotypes with the Activity of PON1 in Patients with Parkinson's Disease.
Mota A; Hemati-Dinarvand M; Akbar Taheraghdam A; Reza Nejabati H; Ahmadi R; Ghasemnejad T; Hasanpour M; Valilo M
Acta Neurol Taiwan; 2019 Sep; 28(3)():66-74. PubMed ID: 32002976
[TBL] [Abstract][Full Text] [Related]
19. Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies.
Bae SS; Shahbazian A; Wang J; Golub I; Oganesian B; Dowd T; Vayngortin B; Wang R; Elashoff D; Reddy ST; Charles-Schoeman C
Rheumatology (Oxford); 2022 May; 61(6):2512-2523. PubMed ID: 34698804
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
